Neurology CME

Credits: 0.25 CME
Medical Learning Institute, Inc.
Current Status and Future Directions in the Treatment of Multiple Sclerosis: What Are the Key Learnings From Stockholm?
Edward J. Fox, MD, PhD
27 December, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Altering the Natural History of Spinal Muscular Atrophy: A Compelling Story Highlighting the Critical Role of Presymptomatic Treatment
Diana Castro, MD
27 December, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Brainstorming Personalized Care Strategies in Glioblastoma: Rethinking and Refining Therapeutic Algorithms With Tumor Treating Fields and Novel Systemic Approaches
Steven Brem, MD
23 December, 2019
Credits: 0.25 CME
Medical Learning Institute, Inc.
Creating a Pathway for the Early Recognition and Optimal Treatment of Amyotrophic Lateral Sclerosis: A Patient’s Journey
Hiroshi Mitsumoto, MD, DSc
6 December, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes
Kathryn Beal, MD / Sandip Patel, MD
4 November, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Generalized Tonic-Clonic Seizures: Clinical Pearls for Recognition and Optimal Management
Joseph I. Sirven, MD
8 October, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Examining Late-Breaking Data on Disease-Modifying Therapies for the Treatment of Multiple Sclerosis — An Update From Philadelphia
Bruce Cree, MD, PhD, MAS
15 July, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Clinical Pearls for the Accurate Diagnosis and Optimal Treatment of Hereditary ATTR Amyloidosis
Michael Polydefkis, MD
11 July, 2019
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers
2 July, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progressive Supranuclear Palsy: Examining Diagnostic Considerations and Emerging Treatment Approaches
Adam Boxer, MD
17 June, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Diminishing the Burden of Phenylketonuria During Adulthood: New Science & Encouraging Stories Highlighting the Critical Role of Adjunctive Therapy in Alleviating Neurocognitive Symptoms and Easing Dietary Constraints
Jerry Vockley, MD, PhD
30 May, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Exploring Unmet Needs in Large Hemispheric Infarction: Clinical Insights on Early Recognition and Emerging Therapy
Kevin N. Sheth, MD
29 May, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Harnessing the Full Potential of Available Therapies for the Treatment of Lennox-Gastaut Syndrome: A Story Behind the Science
Anup Patel, MD, FAAN
29 March, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in Multiple Sclerosis Through the Practice of Shared Decision-Making in Disease-Modifying Therapy Selection
Aaron Boster, MD
4 March, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes
Richard Finn, MD
15 February, 2019
Credits: 0.75 CME
Medical Learning Institute, Inc.
Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?
Marwan Sabbagh, MD, FAAN
30 January, 2019